Current means for identifying the latent stage of a neurodegenerative process
A characteristic feature of neurodegenerative diseases is thepresence of a long-term latent stage, while manifestation ofsymptoms occurs after 4060% cells loss in vulnerable neuronpopulations. Therefore, potential for neuroprotection is maximaljust at the latent stage of the process. In this paper,...
Main Authors: | S. N. Illarioshkin, A. G. Vlassenko, E. Yu. Fedotova |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center of Neurology
2017-02-01
|
Series: | Анналы клинической и экспериментальной неврологии |
Subjects: | |
Online Access: | https://annaly-nevrologii.com/journal/pathID/article/viewFile/236/72 |
Similar Items
-
The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
by: Simran Rastogi, et al.
Published: (2021-01-01) -
Photobiomodulation for Neurodegenerative Diseases: A Scoping Review
by: Qi Shen, et al.
Published: (2024-01-01) -
Editorial: Prodromal stage of neurodegenerative proteinopathies: from bench to bedside
by: Bin Xu, et al.
Published: (2023-09-01) -
Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
by: Anna-Katharine Brem, et al.
Published: (2023-06-01) -
Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders
by: Yoon Ji Kwon, et al.
Published: (2023-05-01)